Showing 2491-2500 of 10466 results for "".
Diagnostic Approach for Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/diagnostic-approach-for-prurigo-nodularis/37137/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, describes his diagnostic algorithm for prurigo nodularis.Antimicrobial Resistance and Psoriasis Remission
https://practicaldermatology.com/series/the-practical-dermatology-podcast/antimicrobial-resistance-and-psoriasis-remission/39042/Jason E. Hawkes, MD, MS, FAAD, discusses a recent consensus paper defining on-treatment remission for plaque psoriasis, and Theodore Rosen, MD, FAAD, joins associate medical editor Elizabeth (Lisa) Swanson, MD, FAAD, to discuss the threat posed by antimicrobial resistance and play “Two Truths and aPractical Dermatology Roundtable: Generalized Pustular Psoriasis, Ch. 4
https://reachmd.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-generalized-pustular-psoriasis-ch-4/32760/Host Neal Bhatia, MD, FAAD, and guests Laura K. Ferris, MD, PhD, FAAD, and Jason E. Hawkes, MD, MS, FAAD, discuss updated guidelines for generalized pustular psoriasis treatment and evaluation in light of the current understanding of the IL-36 pathway, as well as the mechanism of action of spesolimaTreatments for Prurigo Nodularis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/treatments-for-prurigo-nodularis/37156/Alina Bridges, DO, Director of Dermatopathology & Associate Professor in the Department of Dermatology and Anatomic Pathology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, provides an overview of therapeutic options for the treatment of prurigo nodularis.Improving Adherence to Topical Regimens
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/improving-adherence-to-topical-regimens/48780/Zoe Diana Draelos, MD, discusses strategies for improving adherence to topical regimens in chronic atopic dermatitis.Anti-OX40 Ligand Antibody Trials
https://practicaldermatology.com/series/updates-atopic-dermatitis/anti-ox40-ligand-antibody-trials/29531/Lead study author Stephan Weidinger, MD, PhD, Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, discusses the phase 2b STREAM-AD trial, evaluating amlitelimab in adult patients with moderate-to-severe atopic dermatitis.PDRN and Regenerative Medicine Update
https://practicaldermatology.com/conferences/science-of-skin-summit-2025/pdrn-regenerative-medicine-update/39739/Suneel Chilukuri, MD, covers the latest in polydeoxyribonucleotide (PDRN) therapies and regenerative medicine applications in dermatology. This video was recorded at the Science of Skin Summit in Austin, TX.HS Tips and Lizards
https://practicaldermatology.com/series/the-practical-dermatology-podcast/hs-tips-and-lizards/35858/The latest news and updates, plus a psoriasis update from Jashin J. Wu, MD, FAAD, at Music City SCALE, and Jennifer L. Hsiao, MD, joins Practical Dermatology Associate Medical Editor Lisa Swanson, MD, FAAD, to discuss treating hidradenitis suppurativa and play a game of "Two Truths and a Lie."When and How to Use Ancillary Testing
https://reachmd.com/programs/practical-dermatology-updates-in-skin-cancer/when-and-how-to-use-ancillary-testing/35598/Hadas Skupsky, MD, a board-certified dermatologist and dermatopathologist, discusses when a dermatopathologist decides to use ancillary testing for melanoma, how that impacts final diagnosis, and how it can guide treatment decisions.I Came In Like a Wrecking Ball
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/i-came-in-like-a-wrecking-ball/33162/I have to start by warning you, dear reader, that I am writing my first editorial for Practical Dermatology immediately after typing up four appeal letters to insurance companies.